title: Levalbuterol and racemic albuterol: are there therapeutic differences?
authors.forename: R
authors.initials: R
authors.lastname: Ahrens
authors.forename: M
authors.initials: M
authors.lastname: Weinberger
mesh_terms: D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000737:chemistry* / Q000627:therapeutic use*; D000420:Albuterol / Q000009:adverse effects / Q000737:chemistry* / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy; D016535:Bronchial Hyperreactivity / Q000209:etiology; D001986:Bronchial Spasm / Q000209:etiology; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000737:chemistry* / Q000627:therapeutic use*; D004361:Drug Tolerance; D006801:Humans; D013237:Stereoisomerism
chemical_list: D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D000420:Albuterol